NewslettersCancer Stem Cell NewsIdentification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells Through Lead OptimizationBy Bob - November 23, 20220313In order to develop potent and selective CYP4Z1 inhibitors, a series of novel N-hydroxyphenylformamidines were rationally designed and synthesized from a pan-CYP inhibitor HET0016.[Journal of Medicinal Chemistry]AbstractGraphical Abstract